Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > OMER Omeros > Detailed Quotes

OMER Omeros

3.220
-0.250-7.20%
Close 09/29 16:00 ET
High
3.430
Open
3.430
Turnover
996.64K
Low
3.115
Pre Close
3.470
Volume
309.51K
Market Cap
201.99M
P/E(TTM)
1.03
52wk High
8.600
Shares
62.73M
P/E(Static)
1.03
52wk Low
1.855
Float Cap
193.85M
Bid/Ask %
0.00%
Historical High
30.230
Shs Float
60.20M
Volume Ratio
0.68
Historical Low
1.855
Dividend TTM
--
Div Yield TTM
--
P/B
-6.18
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.51%
Amplitude
9.08%
Avg Price
3.220
Lot Size
1
Float Cap
193.85M
Bid/Ask %
0.00%
Historical High
30.230
Shs Float
60.20M
Volume Ratio
0.68
Historical Low
1.855
Dividend TTM
--
P/B
-6.18
Dividend LFY
--
Turnover Ratio
0.51%
Amplitude
9.08%
Avg Price
3.220
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.
CEO: Dr. Gregory A. Demopulos,M.D.
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...